Boston Scientific, a medical device manufacturer based in Marlborough, announced in June that David Wichmann has been elected to its board of directors, effective immediately.
Wichmann recently served as CEO of global conglomerate UnitedHealth Group from 2017 to 2021, according to a release, but his career at the company spanned 23 years in various roles that included president, chief financial officer, and head of operations and commercial markets.
“From his experience leading one of the largest health care organizations in the world, Dave has unique insights about opportunities to improve patient outcomes while also taking costs out of the health care system,” Mike Mahoney, CEO and chairman of the board at Boston Scientific, said in the release.
Prior to joining UnitedHealth Group, Wichmann was a partner at the global accounting firm Arthur Andersen & Co. He has served on the boards of UnitedHealth Group and Tennant Co. and holds a bachelor’s degree in accounting from Illinois State University.
